| Product NDC: | 0088-2100 |
| Proprietary Name: | Priftin |
| Non Proprietary Name: | rifapentine |
| Active Ingredient(s): | 150 mg/1 & nbsp; rifapentine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0088-2100 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021024 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090330 |
| Package NDC: | 0088-2100-03 |
| Package Description: | 4 BLISTER PACK in 1 CARTON (0088-2100-03) > 8 TABLET, FILM COATED in 1 BLISTER PACK |
| NDC Code | 0088-2100-03 |
| Proprietary Name | Priftin |
| Package Description | 4 BLISTER PACK in 1 CARTON (0088-2100-03) > 8 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 0088-2100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rifapentine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090330 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | RIFAPENTINE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient] |